News & Updates
Filter by Specialty:
![Polypharmacy in IBD interferes with treatment adherence, therapeutic success](https://sitmspst.blob.core.windows.net/images/articles/multiplepillstablets714-b02ea399-5bdd-47f1-bf10-b2a1b7e98115-square.jpg)
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
Polypharmacy (PP) arises in nearly one in five patients with inflammatory bowel disease (IBD), particularly in older adults and those with comorbidity, according to a study, adding that PP can complicate adherence to treatment and therapeutic success.
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022![L-arginine, tadalafil boost Li-ESWT effect for ED](https://sitmspst.blob.core.windows.net/images/articles/arginine-tadalafil-ed-157d5508-3ef1-4e30-b214-7e7d8d55d4eb-square.jpg)
L-arginine, tadalafil boost Li-ESWT effect for ED
In men with erectile dysfunction (ED), adjuvant daily oral therapy with L-arginine and tadalafil was effective and safe in enhancing the efficacy and duration of benefits of low-intensity extracorporeal shockwave therapy (Li-ESWT), a study has shown.
L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022![People who trust formal information source more likely to get COVID-19 jab](https://sitmspst.blob.core.windows.net/images/articles/how-social-media-is-changing-healthcare-a5a683ed-0fbf-4bb7-9de3-e3552b05d4c0-square.jpg)
People who trust formal information source more likely to get COVID-19 jab
Among middle-aged and older adults, trust in formal sources of vaccine information, such as government agencies, is a strong predictor of willingness to get vaccinated against the coronavirus disease 2019 (COVID-19), according to a recent Singapore study.
People who trust formal information source more likely to get COVID-19 jab
14 Mar 2022![Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis](https://sitmspst.blob.core.windows.net/images/articles/study-points-to-efficacy-and-safety-of-tyk2-inhibitor-bms-986165-in-psoriasis-a46d6dde-344e-4130-86ae-71c400f0ebbc-square.jpg)
Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis
In the treatment of patients with psoriasis, the combination of adalimumab plus methotrexate is more beneficial than adalimumab alone, reducing antidrug antibody formation and inducing slightly better response, drug survival, and higher serum trough concentrations, according to a study.
Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis
14 Mar 2022![Pregnancies exposed to tramadol not at heightened risk of miscarriage, congenital malformations](https://sitmspst.blob.core.windows.net/images/articles/young-pregnant-woman-with-hands-on-her-back-5246ac12-fd0b-4107-a443-910583f4db17-square.jpg)
Pregnancies exposed to tramadol not at heightened risk of miscarriage, congenital malformations
Tramadol exposure during early pregnancy does not appear to contribute to an increased risk of spontaneous abortion or congenital malformations, a study reports.